JP2007508362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508362A5 JP2007508362A5 JP2006534801A JP2006534801A JP2007508362A5 JP 2007508362 A5 JP2007508362 A5 JP 2007508362A5 JP 2006534801 A JP2006534801 A JP 2006534801A JP 2006534801 A JP2006534801 A JP 2006534801A JP 2007508362 A5 JP2007508362 A5 JP 2007508362A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- solvate
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- 150000003839 salts Chemical class 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- -1 cyano , acetyl Chemical group 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0312143 | 2003-10-17 | ||
| FR0312143A FR2861070B1 (fr) | 2003-10-17 | 2003-10-17 | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| PCT/FR2004/002644 WO2005037785A2 (fr) | 2003-10-17 | 2004-10-15 | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide, et n-[azepan-2-yl) phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007508362A JP2007508362A (ja) | 2007-04-05 |
| JP2007508362A5 true JP2007508362A5 (show.php) | 2011-03-03 |
| JP4700007B2 JP4700007B2 (ja) | 2011-06-15 |
Family
ID=34385236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534801A Expired - Fee Related JP4700007B2 (ja) | 2003-10-17 | 2004-10-15 | Ｎ−［フェニル（ピロリジン−２−イル）メチル］ベンズアミドおよびｎ−［（アゼパン−２−イル）フェニルメチル］ベンズアミド誘導体、この調製方法および治療法における使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7226917B2 (show.php) |
| EP (1) | EP1680400B1 (show.php) |
| JP (1) | JP4700007B2 (show.php) |
| CN (1) | CN1882534A (show.php) |
| AT (1) | ATE364038T1 (show.php) |
| AU (1) | AU2004281218B2 (show.php) |
| BR (1) | BRPI0415511A (show.php) |
| CA (1) | CA2542727A1 (show.php) |
| CY (1) | CY1106827T1 (show.php) |
| DE (1) | DE602004006891T2 (show.php) |
| DK (1) | DK1680400T3 (show.php) |
| ES (1) | ES2286689T3 (show.php) |
| FR (1) | FR2861070B1 (show.php) |
| HR (1) | HRP20070307T3 (show.php) |
| IL (1) | IL174934A (show.php) |
| MA (1) | MA28098A1 (show.php) |
| ME (1) | MEP12608A (show.php) |
| NO (1) | NO20062032L (show.php) |
| NZ (1) | NZ547167A (show.php) |
| PL (1) | PL1680400T3 (show.php) |
| PT (1) | PT1680400E (show.php) |
| RS (1) | RS20060315A (show.php) |
| RU (1) | RU2386614C2 (show.php) |
| WO (1) | WO2005037785A2 (show.php) |
| ZA (1) | ZA200603862B (show.php) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2842804B1 (fr) | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861071B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique |
| FR2861074B1 (fr) * | 2003-10-17 | 2006-04-07 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861070B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| PE20061156A1 (es) | 2004-12-23 | 2006-12-16 | Glaxo Group Ltd | Derivados de benzamida como agentes inhibidores del transportador de glicina |
| GB0612420D0 (en) * | 2006-06-22 | 2006-08-02 | Glaxo Group Ltd | Compounds |
| JP5619609B2 (ja) | 2007-08-22 | 2014-11-05 | アボット ゲーエムベーハーウント カンパニー カーゲー | ４−ベンジルアミノキノリン類、これらを含む医薬組成物およびこれらの使用 |
| CN102083797B (zh) | 2008-04-01 | 2014-06-04 | Abbvie公司 | 四氢异喹啉、含有它们的药物组合物和它们在治疗中的用途 |
| CN102405222A (zh) * | 2009-01-28 | 2012-04-04 | 阿斯利康(瑞典)有限公司 | 2-氮杂-二环[2.2.1]庚烷化合物及其用途 |
| FR2941954B1 (fr) * | 2009-02-10 | 2011-04-08 | Sanofi Aventis | Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique |
| FR2941953B1 (fr) * | 2009-02-10 | 2011-04-08 | Sanofi Aventis | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-benzamide, leur preparation et leur application en therapeutique |
| TW201038569A (en) | 2009-02-16 | 2010-11-01 | Abbott Gmbh & Co Kg | Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy |
| AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
| FR2943056A1 (fr) * | 2009-03-16 | 2010-09-17 | Sanofi Aventis | Derives de n-°2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique |
| CN102356074A (zh) * | 2009-03-16 | 2012-02-15 | 赛诺菲 | N-[(2-氮杂-二环[2.1.1]己-1-基)-芳基-)甲基]-杂苯甲酰胺的衍生物，它们的制备和它们在治疗中的应用 |
| US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9045459B2 (en) | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9309200B2 (en) | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| TW201319049A (zh) | 2011-08-05 | 2013-05-16 | Abbott Gmbh & Co Kg | 胺基□唍、胺基硫□唍及胺基－１，２，３，４－四氫喹啉衍生物，包含彼等之醫藥組合物及彼等於治療之用途 |
| JP2014533675A (ja) | 2011-11-18 | 2014-12-15 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | Ｎ置換アミノベンゾシクロヘプテン、アミノテトラリン、アミノインダンおよびフェナルキルアミン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
| US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CN102692463A (zh) * | 2012-06-13 | 2012-09-26 | 山东凯盛新材料股份有限公司 | 高效液相色谱法检测芳香族酰氯类产品的方法 |
| US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| JP2016533375A (ja) | 2013-10-17 | 2016-10-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
| CA2924689A1 (en) | 2013-10-17 | 2015-04-23 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| US9550754B2 (en) | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254569A (en) * | 1991-01-14 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | (Amidomethyl)nitrogen heterocyclic analgesics |
| JP3026845B2 (ja) * | 1991-02-20 | 2000-03-27 | 日清製粉株式会社 | ピペリジン誘導体 |
| AU3254499A (en) * | 1998-03-06 | 1999-09-20 | Janssen Pharmaceutica N.V. | Glycine transport inhibitors |
| DE1073432T1 (de) * | 1998-04-14 | 2002-02-07 | The General Hospital Corp., Boston | Verwendung von glycinrezeptoragonisten und glycinaufnahmeinhibitoren zur behandlung neuropsychiatrischer beschwerden |
| FR2838739B1 (fr) * | 2002-04-19 | 2004-05-28 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique |
| FR2842804B1 (fr) * | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| TW200526626A (en) * | 2003-09-13 | 2005-08-16 | Astrazeneca Ab | Chemical compounds |
| FR2861070B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| AU2006235400A1 (en) * | 2005-04-11 | 2006-10-19 | Yale University | Method of treating schizophrenia prodrome |
-
2003
- 2003-10-17 FR FR0312143A patent/FR2861070B1/fr not_active Expired - Fee Related
-
2004
- 2004-10-15 RS YUP-2006/0315A patent/RS20060315A/sr unknown
- 2004-10-15 CA CA002542727A patent/CA2542727A1/fr not_active Abandoned
- 2004-10-15 DE DE602004006891T patent/DE602004006891T2/de not_active Expired - Lifetime
- 2004-10-15 EP EP04791555A patent/EP1680400B1/fr not_active Expired - Lifetime
- 2004-10-15 HR HR20070307T patent/HRP20070307T3/xx unknown
- 2004-10-15 PL PL04791555T patent/PL1680400T3/pl unknown
- 2004-10-15 PT PT04791555T patent/PT1680400E/pt unknown
- 2004-10-15 RU RU2006116890/04A patent/RU2386614C2/ru not_active IP Right Cessation
- 2004-10-15 JP JP2006534801A patent/JP4700007B2/ja not_active Expired - Fee Related
- 2004-10-15 NZ NZ547167A patent/NZ547167A/en not_active IP Right Cessation
- 2004-10-15 WO PCT/FR2004/002644 patent/WO2005037785A2/fr not_active Ceased
- 2004-10-15 ES ES04791555T patent/ES2286689T3/es not_active Expired - Lifetime
- 2004-10-15 ME MEP-126/08A patent/MEP12608A/xx unknown
- 2004-10-15 AU AU2004281218A patent/AU2004281218B2/en not_active Ceased
- 2004-10-15 BR BRPI0415511-4A patent/BRPI0415511A/pt not_active IP Right Cessation
- 2004-10-15 CN CNA2004800338510A patent/CN1882534A/zh active Pending
- 2004-10-15 AT AT04791555T patent/ATE364038T1/de active
- 2004-10-15 ZA ZA200603862A patent/ZA200603862B/en unknown
- 2004-10-15 DK DK04791555T patent/DK1680400T3/da active
-
2006
- 2006-04-11 IL IL174934A patent/IL174934A/en not_active IP Right Cessation
- 2006-04-17 MA MA28943A patent/MA28098A1/fr unknown
- 2006-04-17 US US11/405,191 patent/US7226917B2/en not_active Expired - Fee Related
- 2006-05-05 NO NO20062032A patent/NO20062032L/no not_active Application Discontinuation
-
2007
- 2007-04-30 US US11/741,803 patent/US7700585B2/en not_active Expired - Fee Related
- 2007-08-31 CY CY20071101114T patent/CY1106827T1/el unknown